NovaBridge Biosciences Debt Securities, Available-for-sale, Amortized Cost, Noncurrent
NovaBridge Biosciences (NBP) had Debt Securities, Available-for-sale, Amortized Cost, Noncurrent of $0 as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Notes
us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent · last filed 2026-04-07
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost, Noncurrent $0.00.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost, Noncurrent $38.73M.
- 2025-06-30: Debt Securities, Available-for-sale, Amortized Cost, Noncurrent $38.73M.
- 2024-12-31: Debt Securities, Available-for-sale, Amortized Cost, Noncurrent $38.73M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost, Noncurrent |
|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-04-07 |
| 2025-09-30 | $38.73M 6-K · filed 2025-12-18 |
| 2025-06-30 | $38.73M 6-K · filed 2025-10-06 |
| 2024-12-31 | $38.73M 20-F · filed 2026-04-07 |
| 2023-12-31 | $0.00 20-F · filed 2025-04-03 |